Arteris Inc
For the period ended Jun 30, 2024. Filed Aug 1, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 1, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
10b5-1 plans:
On May 8, 2024, Paul Alpern, Vice President and General Counsel, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 85,916 shares of the Company’s common stock until August 31, 2025.
On May 20, 2024, Nick Hawkins, Chief Financial Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 171,796 shares of the Company’s common stock until August 31, 2025.
On June 6, 2024, Atiq Raza, Director, as the trustee of Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust Dated November 26, 2012, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 972,472 shares of the Company’s common stock until October 31, 2025.
On June 6, 2024, Isabelle Geday, Director, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 15,550 shares of the Company’s common stock until September 8, 2025.
On June 7, 2024, Wayne Cantwell, Director, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 180,000 shares of the Company’s common stock until August 31, 2025.
On June 12, 2024, Antonio Viana, Director, as the trustee of Viana Family Trust, terminated a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) and originally adopted on November 13, 2023 for the sale of up to 227,777 shares of the Company’s common stock until April 30, 2025.
On June 13, 2024, Antonio Viana, Director, as the trustee of Viana Family Trust, adopted a Rule 10b5-1 trading arrangement of Viana Family Trust that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 223,309 shares of the Company’s common stock until September 30, 2025.
Change in Control Agreement:
On July 30, 2024, the Company executed amended and restated change in control executive severance agreements (each, the A&R Severance Agreement and together, the A&R Severance Agreements) with certain Company executives, including with K. Charles Janac, Laurent Moll and Nicholas B. Hawkins. The A&R Severance Agreements, which replace earlier versions, are substantively consistent with the severance agreements earlier approved by the Board in September 2021; however, the A&R Severance Agreements now contain an auto-renewal provision. The foregoing description of the A&R Severance Agreements is qualified in its entirety by reference to the A&R Severance Agreement form, which is filed as Exhibit 10.1 hereto and is incorporated herein by reference.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.